Medtronic plc (MDT) fundamentals from SEC filings — revenue $36.4B, net margin 13.2%, diluted EPS $3.73 in FY2026. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $31.7B | $31.2B | $32.4B | $33.5B | $36.4B |
| Net income | $5.0B | $3.8B | $3.7B | $4.7B | $4.8B |
| Net margin | 15.9% | 12.0% | 11.4% | 13.9% | 13.2% |
| Diluted EPS | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 |
| Free cash flow | $6.0B | $4.6B | $5.2B | $5.2B | $5.4B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home